Open original FDA record ↗Recall record
- FDA identifier
- Z-0679-2020
- Company in FDA record
- Roche Diagnostics Operations, Inc.
- FDA record creation date
- Dec 13, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Homocysteine Reagent, Calibration Failures and Quality Control Recovery Issues on cobas c 701 and 702 modules
Source facts
- Action
- The Urgent Medical Device Correction (UMDC) was sent via Roche issued Urgent Medical Device notification via FedEx (signature required) to the consignee list on 10/04/2019. The letter states issue, health risk nd action to take: Discontinue use and discard the remaining affected product in inventory according to local waste guidelines. Because a replacement lot is currently not available, Roche will issue credit for Homocysteine cobas c packs, lot number 422313, remaining in your inventory. If customers have another validated system (i.e. cobas c501/502) in their lab and wish to set up the Roche Homocysteine assay on one of these modules (different catalog number than that subject to this recall), they will be instructed to contact a Roche Field Specialist for support. " A reimbursement for send out testing to an accredited laboratory will also be provided for those customers without another Roche system available. Contact the Roche Support Network Customer Support Center, 24 hours a day, seven days a week at 1-800-428-2336 if you have questions about the information The UMDC will also be posted to the diagnostics.roche.com website.
- Initiated
- 2019-10-04
- Root cause
- Device Design
- Terminated
- 2020-10-09
- Distribution
- US Nationwide distribution in the states of NJ, HI, IA.
- Recall number
- Z-0679-2020
- Recall status
- Terminated
- CDRH record ID
- 177008
- FDA record created
- 2019-12-13
- Recall event number
- 84018